Thermo Fisher Scientific forecasts annual profit below estimates as research funding declines
Thermo Fisher Scientific beat quarterly estimates but issued a cautious 2026 outlook citing cuts to research funding. The company’s shares fell on the news.
Insights:
Thermo Fisher Scientific Inc. reported fourth-quarter results that exceeded analyst expectations on Thursday but issued a cautious full-year forecast that fell short of Wall Street estimates. The company attributed its weaker outlook to expected continued cuts in academic and government research funding within the US 
USthroughout 2026. Following the announcement on January 29, 2026, shares of Thermo Fisher Scientific Inc.fell 2.24% as investors weighed the impact of persistent funding weakness on future profitability.
USthroughout 2026. Following the announcement on January 29, 2026, shares of Thermo Fisher Scientific Inc.fell 2.24% as investors weighed the impact of persistent funding weakness on future profitability.
